163 related articles for article (PubMed ID: 35280908)
1. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer.
Zhang L; Huang Z; Cai Q; Zhao C; Xiao Y; Quan X; Tang C; Gao J
Front Med (Lausanne); 2022; 9():837143. PubMed ID: 35280908
[TBL] [Abstract][Full Text] [Related]
2. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
[TBL] [Abstract][Full Text] [Related]
3. Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma.
Niu C; Qiu W; Li X; Li H; Zhou J; Zhu H
J Cancer; 2022; 13(8):2584-2593. PubMed ID: 35711845
[TBL] [Abstract][Full Text] [Related]
4. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
[TBL] [Abstract][Full Text] [Related]
5. Low NLRP3 expression predicts a better prognosis of colorectal cancer.
Shi F; Wei B; Lan T; Xiao Y; Quan X; Chen J; Zhao C; Gao J
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33821998
[TBL] [Abstract][Full Text] [Related]
6. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
7. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation.
Li M; Zhao X; Yong H; Xu J; Qu P; Qiao S; Hou P; Li Z; Chu S; Zheng J; Bai J
Cell Death Dis; 2022 Feb; 13(2):99. PubMed ID: 35110545
[TBL] [Abstract][Full Text] [Related]
8. Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides.
Li M; Lu Y; Li Y; Tong L; Gu XC; Meng J; Zhu Y; Wu L; Feng M; Tian N; Zhang P; Xu T; Lin SH; Tong X
Cancer Res; 2019 Jul; 79(14):3689-3701. PubMed ID: 31101762
[No Abstract] [Full Text] [Related]
9. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
10. Transketolase in human Müller cells is critical to resist light stress through the pentose phosphate and NRF2 pathways.
Chen Y; Zhang T; Zeng S; Xu R; Jin K; Coorey NJ; Wang Y; Wang K; Lee SR; Yam M; Zhu M; Chang A; Fan X; Zhang M; Du J; Gillies MC; Zhu L
Redox Biol; 2022 Aug; 54():102379. PubMed ID: 35779441
[TBL] [Abstract][Full Text] [Related]
11. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
12. Function of the pentose phosphate pathway and its key enzyme, transketolase, in the regulation of the meiotic cell cycle in oocytes.
Kim Y; Kim EY; Seo YM; Yoon TK; Lee WS; Lee KA
Clin Exp Reprod Med; 2012 Jun; 39(2):58-67. PubMed ID: 22816071
[TBL] [Abstract][Full Text] [Related]
13. Dual effects for lovastatin in anaplastic thyroid cancer: the pivotal effect of transketolase (TKT) on lovastatin and tumor proliferation.
Wang CY; Shui HA; Chang TC
J Investig Med; 2018 Jun; 66(5):1-9. PubMed ID: 29502067
[TBL] [Abstract][Full Text] [Related]
14. The role of transketolase in human cancer progression and therapy.
Hao S; Meng Q; Sun H; Li Y; Li Y; Gu L; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Biomed Pharmacother; 2022 Oct; 154():113607. PubMed ID: 36030587
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.
Yang H; Wu XL; Wu KH; Zhang R; Ju LL; Ji Y; Zhang YW; Xue SL; Zhang YX; Yang YF; Yu MM
Am J Cancer Res; 2016; 6(11):2690-2699. PubMed ID: 27904781
[TBL] [Abstract][Full Text] [Related]
16. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
18. PARIS reprograms glucose metabolism by HIF-1α induction in dopaminergic neurodegeneration.
Kang H; Jo A; Kim H; Khang R; Lee JY; Kim H; Park CH; Choi JY; Lee Y; Shin JH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2498-2504. PubMed ID: 29287724
[TBL] [Abstract][Full Text] [Related]
19. Silencing of TKTL1 by siRNA inhibits proliferation of human gastric cancer cells in vitro and in vivo.
Yuan W; Wu S; Guo J; Chen Z; Ge J; Yang P; Hu B; Chen Z
Cancer Biol Ther; 2010 May; 9(9):710-6. PubMed ID: 20200485
[TBL] [Abstract][Full Text] [Related]
20. Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition.
Chao YK; Peng TL; Chuang WY; Yeh CJ; Li YL; Lu YC; Cheng AJ
J Cancer; 2016; 7(13):1804-1811. PubMed ID: 27698919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
